NO900032L - Fremgangsmaate for fremstilling av terapeutisk aktive tiazol-forbindelser. - Google Patents
Fremgangsmaate for fremstilling av terapeutisk aktive tiazol-forbindelser.Info
- Publication number
- NO900032L NO900032L NO90900032A NO900032A NO900032L NO 900032 L NO900032 L NO 900032L NO 90900032 A NO90900032 A NO 90900032A NO 900032 A NO900032 A NO 900032A NO 900032 L NO900032 L NO 900032L
- Authority
- NO
- Norway
- Prior art keywords
- tiazol
- compounds
- procedure
- preparation
- therapeutically active
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB898900191A GB8900191D0 (en) | 1989-01-05 | 1989-01-05 | Thiazole compounds,processes for the preparation thereof and pharmaceutical composition comprising the same |
| GB898906575A GB8906575D0 (en) | 1989-03-22 | 1989-03-22 | Thiazole compounds,processes for the preparation thereof and pharmaceutical compositions comprising the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO900032D0 NO900032D0 (no) | 1990-01-04 |
| NO900032L true NO900032L (no) | 1990-07-06 |
Family
ID=26294803
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO90900032A NO900032L (no) | 1989-01-05 | 1990-01-04 | Fremgangsmaate for fremstilling av terapeutisk aktive tiazol-forbindelser. |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0377457A1 (de) |
| JP (1) | JP3003148B2 (de) |
| KR (1) | KR900011765A (de) |
| CN (1) | CN1043936A (de) |
| AU (1) | AU631169B2 (de) |
| CA (1) | CA2007133A1 (de) |
| FI (1) | FI900035A (de) |
| HU (1) | HU205922B (de) |
| IL (1) | IL92939A0 (de) |
| NO (1) | NO900032L (de) |
| PT (1) | PT92786B (de) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0372125A1 (de) * | 1988-11-08 | 1990-06-13 | Akzo N.V. | Oxazol und Thiazol-Derivate |
| WO1992015570A1 (fr) * | 1991-03-07 | 1992-09-17 | Hisamitsu Pharmaceutical Co., Inc. | Nouveau derive de diphenylthiazole |
| CA2129995C (en) * | 1992-02-13 | 2000-04-11 | Albert A. Carr | Piperidinyl thiacyclic derivatives |
| EP0582164B1 (de) * | 1992-07-31 | 1998-12-23 | Bristol-Myers Squibb Company | Diphenyl Oxazole-, Thiazole- und Imidazole-Derivate als Inhibitoren der Wiederaufnahme des Adenosins |
| TWI292316B (en) * | 1999-10-11 | 2008-01-11 | Sod Conseils Rech Applic | Pharmaceutical composition of thiazole derivatives intended to inhibit mao and/or lipidic peroxidation and/or to act as modulators of sodium channels and the use thereof |
| US20020183316A1 (en) * | 2000-10-27 | 2002-12-05 | Kevin Pan | Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders |
| AR038966A1 (es) * | 2002-03-18 | 2005-02-02 | Solvay Pharm Bv | Derivados de tiazol que tienen actividad antagonista, agonista o agonista parcial de cb1 |
| GB0216700D0 (en) | 2002-07-18 | 2002-08-28 | Astrazeneca Ab | Process |
| US7074809B2 (en) | 2002-08-09 | 2006-07-11 | Astrazeneca Ab | Compounds |
| KR20050033070A (ko) | 2002-08-09 | 2005-04-08 | 아스트라제네카 에이비이 | 메타보트로픽 글루타메이트 수용체-5의 조절제로서[1,2,4]옥사디아졸 |
| WO2004014370A2 (en) * | 2002-08-09 | 2004-02-19 | Astrazeneca Ab | Oxadiazoles as modulators of metabotropic glutamate receptor-5 |
| US20040198800A1 (en) * | 2002-12-19 | 2004-10-07 | Geoffrey Allan | Lipoxygenase inhibitors as hypolipidemic and anti-hypertensive agents |
| GB0230087D0 (en) * | 2002-12-24 | 2003-01-29 | Astrazeneca Ab | Therapeutic agents |
| GB0302673D0 (en) | 2003-02-06 | 2003-03-12 | Astrazeneca Ab | Pharmaceutical formulations |
| GB0302672D0 (en) * | 2003-02-06 | 2003-03-12 | Astrazeneca Ab | Pharmaceutical formulations |
| JP2006182648A (ja) * | 2003-04-08 | 2006-07-13 | Dai Ichi Seiyaku Co Ltd | ７員複素環誘導体 |
| CA2522536A1 (en) * | 2003-04-21 | 2004-11-04 | Daiichi Pharmaceutical Co., Ltd. | Five-membered heterocyclic derivative |
| TWI336697B (en) * | 2003-09-19 | 2011-02-01 | Solvay Pharm Bv | Thiazole derivatives as cannabinoid receptor modulators |
| JP2007513872A (ja) * | 2003-10-24 | 2007-05-31 | ゾルファイ ファーマスーティカルズ ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ｃｂ１拮抗作用を示す化合物の新規の医学的用途および前記化合物を伴う組み合わせ治療 |
| RU2007119315A (ru) | 2004-10-25 | 2008-11-27 | Зольвай Фармасьютиклз Гмбх (De) | Фармацевтические композиции, содержащие антагонисты каннабиноидного рецептора св1 и открыватели калиевых каналов, предназначенные для лечения сахарного диабета типа i, ожирения и связанных с ними состояний |
| DE102009038123A1 (de) | 2009-08-17 | 2011-02-24 | Aicuris Gmbh & Co. Kg | Substituierte (Thiazolyl-carbonyl)imidazolidinone und ihre Verwendung |
| CN114507217A (zh) * | 2016-10-12 | 2022-05-17 | 三角研究所 | 杂环爱帕琳肽受体(apj)激动剂及其用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1496787A (en) * | 1974-03-12 | 1978-01-05 | Smith Kline French Lab | Heteroalkylthioalkyl amidine derivatives |
| AU539801B2 (en) * | 1980-10-14 | 1984-10-18 | Pfizer Inc. | Intermediates in the preparation of 2-guanidino-4- heteroarylthiazoles |
| DE3413755A1 (de) * | 1984-04-12 | 1985-10-24 | Basf Ag, 6700 Ludwigshafen | Thiazolylharnstoffe, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses |
| DE3621775A1 (de) * | 1986-03-13 | 1988-01-07 | Thomae Gmbh Dr K | Neue substituierte thiazole und oxazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
| GB8714789D0 (en) * | 1987-06-24 | 1987-07-29 | Lundbeck & Co As H | Heterocyclic compounds |
-
1989
- 1989-12-29 JP JP1343984A patent/JP3003148B2/ja not_active Expired - Lifetime
- 1989-12-31 IL IL92939A patent/IL92939A0/xx unknown
-
1990
- 1990-01-04 FI FI900035A patent/FI900035A/fi not_active Application Discontinuation
- 1990-01-04 CN CN90100083A patent/CN1043936A/zh active Pending
- 1990-01-04 NO NO90900032A patent/NO900032L/no unknown
- 1990-01-04 CA CA002007133A patent/CA2007133A1/en not_active Abandoned
- 1990-01-04 EP EP90100123A patent/EP0377457A1/de not_active Withdrawn
- 1990-01-04 HU HU9041A patent/HU205922B/hu not_active IP Right Cessation
- 1990-01-04 KR KR1019900000035A patent/KR900011765A/ko not_active Application Discontinuation
- 1990-01-04 AU AU47687/90A patent/AU631169B2/en not_active Ceased
- 1990-01-05 PT PT92786A patent/PT92786B/pt active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| HU900041D0 (en) | 1990-03-28 |
| PT92786B (pt) | 1996-01-31 |
| FI900035A0 (fi) | 1990-01-04 |
| AU631169B2 (en) | 1992-11-19 |
| CA2007133A1 (en) | 1990-07-05 |
| JP3003148B2 (ja) | 2000-01-24 |
| PT92786A (pt) | 1990-07-31 |
| AU4768790A (en) | 1990-07-12 |
| HU205922B (en) | 1992-07-28 |
| IL92939A0 (en) | 1990-09-17 |
| NO900032D0 (no) | 1990-01-04 |
| JPH0327370A (ja) | 1991-02-05 |
| EP0377457A1 (de) | 1990-07-11 |
| KR900011765A (ko) | 1990-08-02 |
| HUT54129A (en) | 1991-01-28 |
| CN1043936A (zh) | 1990-07-18 |
| FI900035A (fi) | 1990-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO871267L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tiazepinforbindelser. | |
| NO904694D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater. | |
| NO179584C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-acylaminotiazoler | |
| NO901684L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater. | |
| NO872946D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzensulfonamidoindanylforbindelser. | |
| NO175978C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive bis-aza-bicykliske forbindelser | |
| NO900032L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tiazol-forbindelser. | |
| NO902411D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-hydroksy-n-propylaminer. | |
| NO864879D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tiasolforbindelser. | |
| NO903941D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive diazepinon-derivater. | |
| NO883485L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive piperidinyl-isokinolinforbindelser. | |
| NO890155D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive indolpiperidin-forbindelser. | |
| NO880667L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive arylpiperazinyl-alkylen-fenyl-heterocykliske forbindelser. | |
| NO174203C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive | |
| NO873514L (no) | Fremgangsmaate for fremstilling av farmasoeytisk aktive forbindelser. | |
| NO904800L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive karbamater. | |
| NO304428B1 (no) | AnalogifremgangsmÕte for fremstilling av terapeutisk aktive vinylazoler | |
| NO168530C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzoksazoninforbindelser. | |
| NO900972D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive naftalen-derivater. | |
| NO882281D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider. | |
| NO903397L (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme derivater av protocatechualdehyd. | |
| NO900942D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive azacyklooktadien-derivater. | |
| NO892469D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive diazepinon-forbindelser. | |
| NO883959L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive fenolestere. | |
| NO882282L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider. |